Press Releases - 2025-03-31

Date	Title	Company
31-Mar-2025	Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine	Moderna
31-Mar-2025	Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025	Novo Nordisk
31-Mar-2025	Lilly's lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels	Lilly
31-Mar-2025	Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line mantle cell lymphoma	AstraZeneca
31-Mar-2025	Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer	AstraZeneca
31-Mar-2025	NLS Pharmaceutics and Kadimastem Announces Up to $3 Million Equity Financing and $25 Million Equity Facility Agreement	ACCESS NewsWire
31-Mar-2025	Rancho BioSciences Appoints Marc Ginsky as Chief Executive Officer	ACCESS NewsWire
31-Mar-2025	The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium	ACCESS NewsWire
31-Mar-2025	ZetrOZ Systems to Showcase sam(R) Wearable Ultrasound Unit for Pro Football Trainers	ACCESS NewsWire
31-Mar-2025	ONI's LNP Profiler Kit With AutoLNP: Revolutionizing Lipid Nanoparticle Characterization With Super-Resolution Microscopy	ACCESS NewsWire
31-Mar-2025	International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results	ACCESS NewsWire
31-Mar-2025	CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results	ACCESS NewsWire
31-Mar-2025	Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women’s Health Award	ACCESS NewsWire
31-Mar-2025	Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	ACCESS NewsWire
31-Mar-2025	Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure	ACCESS NewsWire
31-Mar-2025	Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023	ACCESS NewsWire
31-Mar-2025	Simulab Corporation Announces Promotion of Woody Salmonsen to Director of Sales, North America	ACCESS NewsWire
31-Mar-2025	Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year	ACCESS NewsWire
31-Mar-2025	Interactive Strength Inc. (Nasdaq: TRNR) Reports Fourth Quarter & Year-End 2024 Results	ACCESS NewsWire
31-Mar-2025	Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults	ACCESS NewsWire